L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lytix Biopharma AS
Current Portion of Long-Term Debt Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Current Portion of Long-Term Debt
kr451k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Current Portion of Long-Term Debt
kr77m
CAGR 3-Years
90%
CAGR 5-Years
21%
CAGR 10-Years
6%
B
Bergenbio ASA
OSE:BGBIO
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Current Portion of Long-Term Debt
kr3.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Current Portion of Long-Term Debt
$1.4m
CAGR 3-Years
144%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Current Portion of Long-Term Debt
kr400k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Lytix Biopharma AS's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
451k NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Current Portion of Long-Term Debt amounts to 451k NOK.

What is Lytix Biopharma AS's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 1Y
-48%

Over the last year, the Current Portion of Long-Term Debt growth was -48%.

Back to Top